The rise in the incidence rate of ankylosing spondylitis, the elevating focus on R&D activities, and lack of approval of therapies have resulted in boosting the Ankylosing Spondylitis Drugs market.
The global ankylosing spondylitis drugs market is forecast to reach USD 8,413.0 Million by 2028, according to a new report by Reports and Data. Ankylosing...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian